[1] LOISELLE M C,STER C,TALBOT B G,et al.Impact of postpartum milking frequency on the immune system and the blood metabolite concentration of dairy cows[J].Journal of Dairy Science,2009,92(5):1900-1912. [2] MOLINERI A I,CAMUSSONE C,ZBRUN M V,et al.Antimicrobial resistance of Staphylococcus aureus isolated from bovine mastitis:Systematic review and meta-analysis[J].Preventive Veterinary Medicine,2021,188:105261. [3] RAZA A,MUHAMMAD G,RAHMAN S U,et al.Evaluation of humoral immunity and protective efficacy of biofilm producing Staphylococcus aureus bacterin-toxoid prepared from a bovine mastitis isolate in rabbit[J].Iranian Journal of Veterinary Research,2015,16(1):69-74. [4] WANG X F,ZHANG S L,ZHU L Y,et al.Enhancement of antibacterial activity of tilmicosin against Staphylococcus aureus by solid lipid nanoparticles in vitro and in vivo[J].The Veterinary Journal,2012,191(1):115-120. [5] 王 宁.替米考星凝胶微丸的制备工艺及质量标准的研究[D].太原:山西医科大学,2009. WANG N.Study on the preparation technology and quality standard of the micmicsky gel pellets[D].Taiyuan:Shanxi Medical University,2009.(in Chinese) [6] ALGHARIB S A,DAWOOD A,XIE S Y.Nanoparticles for treatment of bovine Staphylococcus aureus mastitis[J].Drug Delivery,2020,27(1):292-308. [7] 商 飞.奶牛乳房炎致病菌生物被膜形成机制研究[D].合肥:安徽农业大学,2018. SHANG F.Study on biofilm formation mechanism of pathogenic bacteria of cow mastitis[D].Hefei:Anhui Agricultural University,2018.(in Chinese) [8] AYGVL A,ZTVRK ,ILLI F F,et al.Quercetin inhibits swarming motility and activates biofilm production of Proteus mirabilis possibly by interacting with central regulators,metabolic status or active pump proteins[J].Phytomedicine,2019,57:65-71. [9] MU Y Q,ZENG H,CHEN W.Quercetin inhibits biofilm formation by decreasing the production of EPS and altering the composition of EPS in Staphylococcus epidermidis[J].Frontiers in Microbiology,2021,12:631058. [10] 李阳杰,姜亚玲,刘秋伟.槲皮素衍生物的生物活性研究进展[J].中国药学杂志,2021,56(3):173-180. LI Y J,JIANG Y L,LIU Q W.Research progress on bioactivity of quercetin derivatives[J].Chinese Journal of Pharmacy,2021,56(3):173-180.(in Chinese) [11] MASSI A,BORTOLINI O,RAGNO D,et al.Research progress in the modification of quercetin leading to anticancer agents[J].Molecules,2017,22(8):1270. [12] 中国兽药典委员会.中华人民共和国兽药典:2010版一部[M].北京:中国农业出版社,2011. CHINA VETERINARY PHARMACOPOEIA COMMITTEE.Veterinary Pharmacopoeia of the People’s Republic of China:Volume Ⅰ,2010 Edition[M].Beijing:China Agricultural Press,2011.(in Chinese) [13] JONG A D, THOMAS V,SIMJEE S,et al.Antimicrobial susceptibility monitoring of respiratory tract pathogens isolated from diseased cattle and pigs across Europe:The VetPath study[J].Veterinary Microbiology,2014,172(1-2):202-215. [14] KLEINERT F,KALLIES R,HORT M,et al.Influence of IS256 on genome variability and formation of SCV in Staphylococcus aureus[J].Antimicrobial Agents and Chemotherapy,2017,61(8):e00144-17. [15] LEE J,ZILM P S,KIDD S P.Novel research models for Staphylococcus aureus small colony variants (SCV) development:Co-pathogenesis and growth rate[J].Frontiers in Microbiology,2020,11:321. [16] ABAD L,JOSSE J,TASSE J,et al.Antibiofilm and intraosteoblastic activities of rifamycins against Staphylococcus aureus:Promising in vitro profile of rifabutin[J].Journal of Antimicrobial Chemotherapy,2020,75(6):1466-1473. [17] KIM N H,KANG Y M,HAN W D,et al.Small-colony variants in persistent and recurrent Staphylococcus aureus bacteremia[J].Microbial Drug Resistance,2016,22(7):538-544. [18] WATANABE Y,OIKAWA N,HARIU M,et al.Evaluation of agar culture plates to efficiently identify small colony variants of methicillin-resistant Staphylococcus aureus[J].Infection and Drug Resistance,2019,12:1743-1748. [19] OLIVEIRA P R,CARVALHO V C,LIMA A.Optimizing the treatment of osteomyelitis with antimicrobial drugs[J].Current Orthopaedic Practice,2017,28(2):208-212. [20] MEMARIANI H,MEMARIANI M,GHASEMIAN A.An overview on anti-biofilm properties of quercetin against bacterial pathogens[J].World Journal of Microbiology and Biotechnology,2019,35(9):143. [21] ZENG Y,NIKITKOVA A,ABDELSALAM H,et al.Activity of quercetin and kaemferol against Streptococcus mutans biofilm[J].Archives of Oral Biology,2018,98:9-16. [22] YU L M,SHANG F,CHEN X L,et al.The anti-biofilm effect of silver-nanoparticle-decorated quercetin nanoparticles on a multi-drug resistant Escherichia coli strain isolated from a dairy cow with mastitis[J].PeerJ,2018,6(10):e5711. [23] CHEN X,MCCLEMENTS D J,ZHU Y,et al.Enhancement of the solubility,stability and bioaccessibility of quercetin using protein-based excipient emulsions[J].Food Research International,2018,114:30-37. [24] LIU Y D,CHEN D M,ZHANG A X,et al.Composite inclusion complexes containing hyaluronic acid/chitosan nanosystems for dual responsive enrofloxacin release[J].Carbohydrate Polymers,2021,252:117162. [25] ALGHARIB S A,DAWOOD A,ZHOU K,et al.Designing,structural determination and biological effects of rifaximin loaded chitosan-carboxymethyl chitosan nanogel[J].Carbohydrate Polymers,2020,248:116782. [26] CHEN X J,WANG T,LU M M,et al.Preparation and evaluation of tilmicosin-loaded hydrogenated castor oil nanoparticle suspensions of different particle sizes[J].International Journal of Nanomedicine,2014,9:2655-2664. [27] YANG Y,YUAN L,LI J,et al.Preparation and evaluation of tilmicosin microspheres and lung-targeting studies in rabbits[J].The Veterinary Journal,2019,246:27-34. [28] Al-QUSHAWI A,RASSOULI A,ATYABI F,et al.Preparation and characterization of three tilmicosin-loaded lipid nanoparticles:Physicochemical properties and in-vitro antibacterial activities[J].Iranian Journal of Pharmaceutical Research,2016,15(4):663-676. [29] STEWART E J,GANESAN M,YOUNGER J G,et al.Artificial biofilms establish the role of matrix interactions in staphylococcal biofilm assembly and disassembly[J].Scientific Reports,2015,5:13081. [30] GREGORIO E D,ESPOSITO A,VOLLARO A,et al.N-nonyloxypentyl-l-deoxynojirimycin inhibits growth,biofilm formation and virulence factors expression of Staphylococcus aureus[J].Antibiotics,2020,9(6):362. [31] ZHOU K X,WANG X F,CHEN D M,et al.Enhanced treatment effects of tilmicosin against Staphylococcus aureus cow mastitis by self-assembly sodium alginate-chitosan nanogel[J].Pharmaceutics,2019,11(10):524. [32] LUO W H,QIN H,CHEN D M,et al.The dose regimen formulation of tilmicosin against Lawsonia intracellularis in pigs by pharmacokinetic-pharmacodynamic (PK-PD) model[J].Microbial Pathogenesis,2020,147:104389. [33] LUO W H,CHEN D M,WU M R,et al.Pharmacokinetics/pharmacodynamics models of veterinary antimicrobial agents[J].Journal of Veterinary Science,2019,20(5):e40. |